Polydopamine/Transferrin Hybrid Nanoparticles for Targeted Cell-Killing.

Hauser D, Estermann M, Milosevic A, Steinmetz L, Vanhecke D, Septiadi D, Drasler B, Petri-Fink A, Ball V, Rothen-Rutishauser B

Open source

DOI: 10.3390/nano8121065
Published: 2018 Dec 17
Container: Nanomaterials (Basel, Switzerland)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/nano8121065,
  title = {Polydopamine/Transferrin Hybrid Nanoparticles for Targeted Cell-Killing.},
  author = {Hauser D and Estermann M and Milosevic A and Steinmetz L and Vanhecke D and Septiadi D and Drasler B and Petri-Fink A and Ball V and Rothen-Rutishauser B},
  year = {2018},
  journal = {Nanomaterials (Basel, Switzerland)},
  doi = {10.3390/nano8121065},
  url = {https://doi.org/10.3390/nano8121065}
}

RIS

TY  - JOUR
TI  - Polydopamine/Transferrin Hybrid Nanoparticles for Targeted Cell-Killing.
AU  - Hauser D
AU  - Estermann M
AU  - Milosevic A
AU  - Steinmetz L
AU  - Vanhecke D
AU  - Septiadi D
AU  - Drasler B
AU  - Petri-Fink A
AU  - Ball V
AU  - Rothen-Rutishauser B
PY  - 2018
JO  - Nanomaterials (Basel, Switzerland)
DO  - 10.3390/nano8121065
UR  - https://doi.org/10.3390/nano8121065
ER  -

APA

D, H., M, E., A, M., L, S., D, V., D, S., B, D., A, P., V, B., & B, R. (2018). Polydopamine/Transferrin Hybrid Nanoparticles for Targeted Cell-Killing.. Nanomaterials (Basel, Switzerland). https://doi.org/10.3390/nano8121065

Source records

pubmed · retrieved 2026-11-10T08:44:57.208Z